Synthesis and cytotoxic evaluation of novel quinozalinone derivatives with substituted benzimidazole in position 3

(2019) Synthesis and cytotoxic evaluation of novel quinozalinone derivatives with substituted benzimidazole in position 3. Research in Pharmaceutical Sciences. pp. 247-254. ISSN 1735-5362

[img]
Preview
Text
10001.pdf

Download (455kB) | Preview

Abstract

Quinazolinone and benzimidazole are both fused heterocyclic compounds which have shown valuable biological properties including cytotoxic, antibacterial, and antifungal activities. In this study, a series of novel quinazolinone derivatives substituted with benzimidazole were synthesized in two parts. In the first part 2 - phenyl - 1H - benzimidazol - 6 - amine (4) was synthesized from the reaction of 4-nitro-o-phenylenediamine and benzoic acid. In the second part, new 3-(2-phenyl-1H benzoimidazol-5-yl)- 3H-quinazolin-4-one derivatives (8a-8f) were also prepared. Finally compound 4 was reacted with the different benzoxazinone derivatives (8a-8f) to give the target compounds. The structures of the synthesized compounds were confirmed by IR and (HNMR)-H-1. Cytotoxic activities of the final compounds were assessed at 100, 200, 300, 400, and 500 mM against MCF-7 and HeLa cell lines using the MTT colorimetric assay. Almost all compounds exhibited good cytotoxic activity against both cell lines. Compound 9d demonstrated the highest cytotoxic activity against MCF7 and Hela cell lines with IC50 70 mM and 50 mM, respectively.

Item Type: Article
Keywords: dihydrofolate-reductase inhibition quinazolinone discovery cell
Subjects: QV Pharmacology
Divisions: Faculty of Pharmacy and Pharmaceutical Sciences > Department of Clinical Biochemistry
Isfahan Pharmaceutical Sciences Research center
Other
Page Range: pp. 247-254
Journal or Publication Title: Research in Pharmaceutical Sciences
Journal Index: ISI
Volume: 14
Number: 3
Identification Number: https://doi.org/10.4103/1735-5362.258493
ISSN: 1735-5362
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/10001

Actions (login required)

View Item View Item